In The States – Page 343 – Weekly news about states

Texas

At the May 7 Board of Pharmacy meeting, the Board adopted Option 3, higher fees for both pharmacists and pharmacies to help pay for the integration of the prescription monitoring program. The proposed rule will be finalized at the next Board meeting in August.

Also in Texas… The Health and Human Services Commission (HHSC) announced that later this year HHSC will expand the Medicaid and CHIP benefit to allow pharmacists “to administer certain medications in a pharmacy setting and includes the administration of certain long-acting anti-psychotics, Vivitrol, and flu vaccines. These products will be added to the Medicaid and CHIP formularies. Pharmacies must be reimbursed for the ingredient cost, dispensing fee, and applicable administration fees for each claim processed.” The Vendor Drug Program will publish additional information in the coming weeks.

Also in Texas… HB 4285, legislation pharmacies supported that would have allowed pharmacists to furnish medication under a physician protocol to anyone 18 years of age and older after 5:00 p.m. weekdays and on weekends, if the results of a CLIA-waived test for influenza are positive, was heard in the House Public Health Committee on May 1.

Also in Texas… HB 3496, legislation that requires a sworn disclosure statement for pharmacies that NACDS successfully amended on behalf of chain pharmacies that are not publicly traded companies, passed the House on May 8.

Also in Texas… The House passed HB 2536, a drug transparency bill requiring certain drug cost information to be provided by drug manufacturers, PBMs and health plans to the Health and Human Services Commission and the Department of Insurance which will be posted on a state website. (HB2536) .

Also in Texas… HB 3441/HB 1757, two bills promoted by pharmacies ensuring payment parity for pharmacies and recognizing pharmacists as practitioners in the Insurance code passed both chambers and will be sent to Gov. Greg Abbott (R) to sign into law.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Angeloni2019-05-16T16:04:19-04:00May 16, 2019|Texas|

Washington

Gov. Jay Inslee (D) has signed into law Substitute SB 5380 (Chapter 314, 2019 Laws) – the Governor’s comprehensive opioid legislation – mandating e-prescribing of Schedule II through V controlled substances with exceptions effective January 1, 2021, increasing the frequency of reporting by dispensing to the state’s prescription monitoring program and expanding options for a pharmacist to dispense an opioid overdose reversal medication pursuant to a collaborative drug therapy agreement, standing order, or protocol in addition to a prescription. It also relieves the Pharmacy Quality Assurance Commission, formerly the Board of Pharmacy, from having to approve all electronic systems.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Angeloni2019-05-16T15:24:24-04:00May 16, 2019|Washington|

South Carolina

The South Carolina Department of Health and Human Services (SCDHHS) will co-sponsor provider and facility training with Keystone Peer Review Organization (KEPRO), the SCDHHS’ quality improvement organization. The annual quality improvement training includes requirements, updates and a review of the process and procedures for prior authorization. The online training sessions will be held Tuesday, May 14 and Thursday, May 16, at 10:00 a.m. and 1:00 p.m. Registration is not required. For questions about the KEPRO training, providers may contact KEPRO at 855-326-5219 or by email.

Karen White2019-05-14T10:07:35-04:00May 9, 2019|South Carolina|

Mississippi

The Division of Medicaid, in conjunction with its contractors Conduent, Alliant UM/QIO and the MSCAN plans – Magnolia Health, Molina Healthcare and UnitedHealthcare Community Plan, will conduct “FREE” Medicaid Provider Workshops beginning Tuesday, June 11 through Tuesday, July 30, at locations throughout the state. These workshops are designed to provide information and changes related to Medicaid and managed care programs. Office directors, office managers, coders, practitioners and billing staff are encouraged to attend. Please RSVP because space is limited.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Karen White2019-05-14T09:53:00-04:00May 9, 2019|Mississippi|

Maryland

NACDS reminds members that beginning Saturday, June 1, all dispensers must begin reporting data to the state’s new prescription drug monitoring program vendor, RxGov. The Department of Health is urging pharmacies to begin this process as soon as possible as they have experienced delays in uploading of data to the new product.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Karen White2019-05-14T09:50:53-04:00May 9, 2019|Maryland|

Kansas

The Board of Pharmacy has been asked to nominate at least two individuals for potential appointment to the vacancy on the Medicaid Drug Utilization Review Board. The vacancy is for a pharmacist who is actively engaged in retail pharmacy and has experience with the State Medicaid Plan. Please have interested candidates submit their name, contact information, letter of interest and CV/resume to the Board’s Executive Secretary, Alexandra Blasi, JD, MBA, no later than Thursday, May 23. Nominations will be considered at the Board’s Thursday, June 6 meeting.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Karen White2019-05-14T09:48:38-04:00May 9, 2019|Kansas|

Indiana

On April 30, the Health Commissioner Kristina Box issued a standing order for the purpose of allowing pharmacists to vaccinate adults against measles. The standing order will be effective until Tuesday, December 31 and provides details on the procedure that should be followed by pharmacies that wish to participate.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Karen White2019-06-27T08:57:32-04:00May 9, 2019|Indiana|

Texas

Legislation, NACDS supports after our amendments were accepted that prohibits the sale of products containing dextromethorphan to persons under the age of 18 years, has passed the House and is pending final action by the Senate. (HB 1518/SB 349)

Also in Texas…HB 1264, legislation filed by Rep. Senfronia Thompson (D), the Chair of the House Public Health Committee, which will repeal the sunset date for pharmacists reporting the dispensing of biologics, passed both the House and Senate, and now is headed to Gov. Greg Abbott (R) to be signed into law.

Also in Texas… NACDS-supported non-controversial clean-up legislation clarifying that pharmacists do not have to do redundant checking of the prescription monitoring program (PMP) when refilling Schedule II-V controlled substances—since both prescribers and dispensers already reviewed the PMP report prior to the initial prescribing and dispensing of the prescription—passed the Senate and is pending in the House. (HB 577/SB 420)

Also in Texas…After negotiations with Rep. Jay Dean (R), Dean agreed to withdraw HB 2086, legislation that would have mandated all pharmacies take back and dispose of unwanted medications free of charge. If a pharmacy does not provide safe disposal options at no cost to the consumer, then the compromise reached with Rep. Dean requires pharmacies to simply include messaging and a link to the Drug Enforcement Administration as part of the patient information provided with every Schedule II controlled substance prescription. The committee substitute bill (CS HB 2088) passed the House Public Health Committee on April 24 and is pending a vote by the full House.

Also in Texas…NACDS successfully negotiated amendments to Rep. Shawn Thierry’s (D) bill that requires pharmacies to add the same auxiliary warning label on opioid prescriptions that has been adopted by five other states—“Caution: Opioid. Risk of overdose and addiction.” (CS HB 562) As part of the compromise, the representative agreed not to pursue two other bills mandating onerous additional opioid counseling and documentation requirements, and the other bill required additional written material on the dangers of opioids, a lengthy warning label in large capital letters, and red caps for all opioid prescriptions. (HB 536 & HB 563)

Also in Texas…HB 2174, legislation mandating all controlled substance be electronically prescribed by Friday, January 1, 2021, and for which NACDS has garnered broad-based support, passed the House on April 26. It was subsequently referred to the Senate Health and Human Services Committee where NACDS hopes to substitute SB 1233—the companion bill filed by Sen. Lois Kolkhorst (R), the chair of the Committee—which was heard in the Committee last month along with the House-passed version.

Also in Texas…Effective April 15, the Health and Human Services Commission (HHSC) implemented the final rules to align reimbursement standards for pharmacy services to conform with the Medicaid State Plan (SP) under 1 TAC §§355.8541, 355.8548, 355.8551. The final rule revisions are consistent with the current SP and federal law and do not constitute a change to current pharmacy reimbursement under Medicaid fee-for-service; reimbursement is calculated consistently with the Medicaid State Plan and federal law. Additionally, the final rule changes under 1 TAC §354.1831 amending regulations to clarify that limited home health supplies listed in the Texas Drug Code Index are covered drugs. Lastly, the rule changes under 1 TAC §354.1867 amend regulations to clarify that early refills of drugs used to treat chronic conditions included in a medication synchronization plan may be jointly approved by the HHSC, the applicable pharmacist, enrollee, and the prescribing physician or healthcare provider. The rule also clarifies that pharmacists must comply with related procedures in the Vendor Drug Program pharmacy provider manual, and that dispensing fees will not be prorated.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Karen White2019-05-03T08:53:42-04:00May 2, 2019|Texas|

Oklahoma

SB 856, legislation by pharmacist Sen. Rob Standridge (R) that would have set the pharmacy technician to pharmacist ratio in statute at 2:1 which passed the Senate last month, died in the House Business and Commerce Committee.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Karen White2019-05-03T08:48:56-04:00May 2, 2019|Oklahoma|